SUSQUEHANNA INTERNATIONAL GROUP, LLP - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is and the CUSIP is 71426VAK4. A total of 15 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q4 2018$50,000
-75.8%
500,0000.0%0.00%
Q3 2018$207,000
-2.8%
500,0000.0%0.00%
Q2 2018$213,000
+0.9%
500,0000.0%0.00%
Q1 2018$211,000
-64.8%
500,000
-66.7%
0.00%
Q4 2017$600,0000.0%1,500,0000.0%0.00%
Q3 2017$600,000
+41.5%
1,500,0000.0%0.00%
Q2 2017$424,000
+66.3%
1,500,0000.0%0.00%
Q1 2017$255,000
-26.1%
1,500,0000.0%0.00%
Q4 2016$345,000
-11.8%
1,500,0000.0%0.00%
Q3 2016$391,000
+13.3%
1,500,0000.0%0.00%
Q2 2016$345,0001,500,0000.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q3 2016
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 10,000,000$1,000,0000.64%
ARMISTICE CAPITAL, LLC 21,760,000$5,723,0000.43%
Avoro Capital Advisors LLC 6,000,000$2,545,0000.15%
Bruce & Co., Inc. 2,000,000$250,0000.05%
ZAZOVE ASSOCIATES LLC 2,000,000$300,0000.03%
Perceptive Advisors 1,000,000$642,0000.02%
TENOR CAPITAL MANAGEMENT Co., L.P. 2,000,000$221,0000.02%
Aisling Capital LLC 2,500,000$16,0000.01%
683 Capital Management, LLC 9,000,000$68,0000.00%
Jefferies Group LLC 5,715,000$57,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders